Michael Fillitz

423 total citations
17 papers, 166 citations indexed

About

Michael Fillitz is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Michael Fillitz has authored 17 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 5 papers in Genetics and 5 papers in Physiology. Recurrent topics in Michael Fillitz's work include Blood groups and transfusion (11 papers), Platelet Disorders and Treatments (10 papers) and Erythrocyte Function and Pathophysiology (4 papers). Michael Fillitz is often cited by papers focused on Blood groups and transfusion (11 papers), Platelet Disorders and Treatments (10 papers) and Erythrocyte Function and Pathophysiology (4 papers). Michael Fillitz collaborates with scholars based in Austria, United Kingdom and Germany. Michael Fillitz's co-authors include James C. Gilbert, Christian Sillaber, Bernd Jilma, Shirley D’Sa, Graham C. Parry, Sandip Panicker, Johann Bartko, Ulla Derhaschnig, Ulrich Jäger and Gary Patou and has published in prestigious journals such as Blood, Journal of Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

Michael Fillitz

11 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fillitz Austria 5 103 90 49 33 27 17 166
Montserrat Torrent Spain 5 54 0.5× 43 0.5× 19 0.4× 9 0.3× 24 0.9× 11 144
Ole Weiss Bjerrum Denmark 5 159 1.5× 86 1.0× 30 0.6× 7 0.2× 90 3.3× 5 190
Thure Mors Haunstrup Denmark 5 60 0.6× 17 0.2× 23 0.5× 72 2.2× 11 0.4× 15 131
Norihiro Murakami Japan 6 43 0.4× 14 0.2× 19 0.4× 11 0.3× 15 0.6× 12 100
Agnieszka Orzińska Poland 9 206 2.0× 77 0.9× 23 0.5× 66 2.0× 54 2.0× 37 268
Maja Klaudel‐Dreszler Poland 7 27 0.3× 16 0.2× 66 1.3× 13 0.4× 10 0.4× 24 123
Nipun Kakkar United States 4 9 0.1× 85 0.9× 27 0.6× 32 1.0× 7 0.3× 4 118
Karen Phaik Har Lim United States 4 10 0.1× 156 1.7× 43 0.9× 69 2.1× 6 0.2× 6 179
Daphne N. Pariser United States 5 52 0.5× 14 0.2× 42 0.9× 11 0.3× 8 0.3× 6 144
Marie Tamagne France 8 125 1.2× 84 0.9× 78 1.6× 15 0.5× 68 2.5× 15 243

Countries citing papers authored by Michael Fillitz

Since Specialization
Citations

This map shows the geographic impact of Michael Fillitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fillitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fillitz more than expected).

Fields of papers citing papers by Michael Fillitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fillitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fillitz. The network helps show where Michael Fillitz may publish in the future.

Co-authorship network of co-authors of Michael Fillitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fillitz. A scholar is included among the top collaborators of Michael Fillitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fillitz. Michael Fillitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zlamal, Jan, Michael Fillitz, Alexander Tolios, et al.. (2025). Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 23(9). 2958–2968.
2.
Reitsma, Stéphanie E., Claire de Moreuil, Michael Fillitz, et al.. (2024). Fibrinolysis is impaired in patients with primary immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 22(11). 3209–3220. 1 indexed citations
4.
Fillitz, Michael, et al.. (2023). Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank. Hämostaseologie. 43(S 01). S72–S73.
5.
Kaider, Alexandra, Beate Eichelberger, Helmuth Haslacher, et al.. (2023). Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia. Thrombosis Research. 223. 102–110. 13 indexed citations
6.
Fillitz, Michael, et al.. (2023). High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia. Blood. 142(Supplement 1). 1208–1208.
7.
Fillitz, Michael, et al.. (2021). Practical considerations for the management of immune thrombocytopenic purpura. memo - Magazine of European Medical Oncology. 14(4). 350–354. 3 indexed citations
8.
Fillitz, Michael, et al.. (2021). Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP). Blood. 138(Supplement 1). 3162–3162.
9.
Feenstra, Jelena D. Milosevic, Fiorella Schischlik, Roland Jäger, et al.. (2020). Overexpression of PD-L1 Correlates with JAK2-V617F Mutational Burden and Is Associated with Chromosome 9p Uniparental Disomy in MPN. Blood. 136(Supplement 1). 24–24. 3 indexed citations
10.
Gelbenegger, Georg, Christian Schoergenhofer, Ulla Derhaschnig, et al.. (2020). Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Blood Advances. 4(6). 997–1005. 23 indexed citations
11.
Jäger, Ulrich, Shirley D’Sa, Christian Schörgenhofer, et al.. (2018). Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. Blood. 133(9). 893–901. 78 indexed citations
12.
Mosheimer, Birgit, Shahin Zandieh, Michael Fillitz, et al.. (2017). Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review. Current Rheumatology Reports. 19(5). 29–29. 33 indexed citations
13.
Jaeger, Ulrich, Shirley D’Sa, Christian Schoergenhofer, et al.. (2017). Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients. Blood. 130(Suppl_1). 703–703. 6 indexed citations
14.
Jilma, Bernd, James C. Gilbert, Sandip Panicker, et al.. (2016). Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD). Blood. 128(22). 2435–2435. 3 indexed citations
15.
Panicker, Sandip, Graham C. Parry, Michael Fillitz, et al.. (2016). TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients. Immunobiology. 221(10). 1170–1171. 2 indexed citations
16.
Fillitz, Michael, et al.. (2015). Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients. memo - Magazine of European Medical Oncology. 8(1). 22–25.
17.
Fillitz, Michael, Heidrun Karlic, Heinz Tüchler, et al.. (2006). Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?. Annals of Hematology. 85(6). 386–393. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026